carbinoxamine maleate 0.8 MG/ML Oral Solution

RxCUI
1010696
RxNorm name
carbinoxamine maleate 0.8 MG/ML Oral Solution
Display name
Carbinoxamine (Oral Liquid)
Full name
carbinoxamine maleate 0.8 MG/ML Oral Solution
Term type
SCD
Status
Active
Strength
4 mg/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-06-13 07:07:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
carbinoxamine maleate0.8 MG / 1 MLcarbinoxaminecarbinoxamine maleate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
carbinoxamine20220

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRcarbinoxamine maleate 0.8 MG/ML Oral SolutionNAMES
RxNorm Namecarbinoxamine maleate 0.8 MG/ML Oral SolutionNAMES
RxNorm Synonymcarbinoxamine maleate 0.8 MG/ML Oral SyrupNAMES
RxNorm Synonymcarbinoxamine maleate 4 MG per 5 ML Oral SolutionNAMES
TTYSCDATTRIBUTES
SPL_SET_ID9d11b197-cfdc-4b9b-9935-2920ccb6e522CODES
RxCUI1010696CODES
MMSL_CODEBD8635CODES
MMSL_CODECD8635CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
64950-243-0464950-243Carbinoxamine Maleate Carbinoxamine MaleateGenus Lifesciences Inc.ANDA040458
64950-243-1664950-243Carbinoxamine Maleate Carbinoxamine MaleateGenus Lifesciences Inc.ANDA040458

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA04045864950-243Carbinoxamine Maleate Carbinoxamine MaleateANDAGenus Lifesciences Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
51991033404rxnav_ndcsyes
51991033416rxnav_ndcsyes
64950024304rxnav_ndcsyes
64950024316rxnav_ndcsyes
00525675204rxnav_historical_indirect
00525675216rxnav_historical_indirect
00525675230rxnav_historical_indirect
15310011001rxnav_historical
15310011004rxnav_historical
18011067516rxnav_historical
46672064101rxnav_historical
46672064104rxnav_historical
46672064116rxnav_historical
46672064404rxnav_historical
46672064416rxnav_historical
51301018015rxnav_historical_indirect
51301018016rxnav_historical_indirect
51991022801rxnav_historical_indirect
51991022816rxnav_historical
54868501900rxnav_historical
55654003716rxnav_historical
55654004640rxnav_historical
58716041216rxnav_historical
58716041240rxnav_historical
59702004004rxnav_historical_indirect
62022025415rxnav_historical
62022025416rxnav_historical_indirect
64376061216rxnav_historical
64376061240rxnav_historical
64376070416rxnav_historical
64376071940rxnav_historical
66239019216rxnav_historical_indirect
71085008007rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9d11b197-cfdc-4b9b-9935-2920ccb6e522carbinoxamine maleate 4 MG in 5 mL Oral SolutionPSN6Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20240306
9d11b197-cfdc-4b9b-9935-2920ccb6e522carbinoxamine maleate 0.8 MG/ML Oral SolutionSCD6Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20240306
9d11b197-cfdc-4b9b-9935-2920ccb6e522carbinoxamine maleate 4 MG per 5 ML Oral SolutionSY6Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20240306
9d11b197-cfdc-4b9b-9935-2920ccb6e522carbinoxamine maleate 0.8 MG/ML Oral SyrupSY6Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20240306
a845fc15-c675-4e33-840c-6a74e79d0cedcarbinoxamine maleate 0.8 MG/ML Oral SolutionSCD3CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20250616
a845fc15-c675-4e33-840c-6a74e79d0cedcarbinoxamine maleate 4 MG per 5 ML Oral SolutionSY3CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20250616
a845fc15-c675-4e33-840c-6a74e79d0cedcarbinoxamine maleate 4 MG in 5 mL Oral SolutionPSN3CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20250616
a845fc15-c675-4e33-840c-6a74e79d0cedcarbinoxamine maleate 0.8 MG/ML Oral SyrupSY3CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20250616

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
a845fc15-c675-4e33-840c-6a74e79d0cedCARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mLIPG Pharmaceuticals, inc.20250616
9d11b197-cfdc-4b9b-9935-2920ccb6e522Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mLGenus Lifesciences Inc. | Mikart20240306

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4carbinoxamine
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epccarbinoxamine
FDASPLN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine maleate
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine maleate
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine maleate
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine maleate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine maleate
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine maleate
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine maleate
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine maleate
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine maleate
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine maleate
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine maleate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine maleate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine maleate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.8 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESANDAANDA040458
CODESMMSL_CODEBD8635
CODESMMSL_CODECD8635
CODESRxCUI1010696
CODESSNOMEDCT409192006
CODESSPL_SET_ID9d11b197-cfdc-4b9b-9935-2920ccb6e522
CODESVUID4032213
CODESVUID4032214
NAMESPrescribable Synonymcarbinoxamine maleate 4 MG in 5 mL Oral Solution
NAMESRXNAV_STRcarbinoxamine maleate 0.8 MG/ML Oral Solution
NAMESRxNorm Namecarbinoxamine maleate 0.8 MG/ML Oral Solution
NAMESRxNorm Synonymcarbinoxamine maleate 0.8 MG/ML Oral Syrup
NAMESRxNorm Synonymcarbinoxamine maleate 4 MG per 5 ML Oral Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File